- ►pharmyaring.com [PDF] SE Inzucchi - Jama, 2002 - Am Med Assoc Context Care of patients with type 2 diabetes has been revolutionized throughout
the past several years—first, by the realization of the importance of tight
glycemic control in forestalling complications, and second, by the ... Cited by 600 - Related articles - BL Direct - All 18 versions
MD Garber, J Alan, MD Duncan, G Theodore, … - The American journal of medicine, 1997 - Elsevier RESULTS: Metformin improved glucose variables as compared with placebo. The
adjusted mean changes in fasting plasma glucose from baseline associated with
each metformin group at week 7, 11, or at endpoint exceeded those ... Cited by 231 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org M St John Sutton, M Rendell, P Dandona, JF … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Of the 203 patients randomly assigned to RSG (4 mg
bid) or glyburide (GLB) (titrated to achieve optimal glycemic control for the
first 8 weeks only to limit the risk of hypoglycemia; mean 10.5 mg/day), ... Cited by 216 - Related articles - BL Direct - All 5 versions
MA Nauck, G Meininger, D Sheng, L Terranella … - Diabetes, Obesity and Metabolism, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 132 - Related articles - All 7 versions
- Free from Publisher BHR Wolffenbuttel, R Landgraf - Diabetes Care, 1999 - Am Diabetes Assoc T ype 2 diabetes is a heterogeneous diso rder characterized by impaire d insulin
secretion, diminished periph- eral insulin action, and increased hepatic glucose
production (1,2). The major thera- peuticgoalsinthesepatients aretooptimize ... Cited by 87 - Related articles - BL Direct - All 5 versions
- ►adisonline.com [PDF] M Rendell - Drugs, 2004 - ingentaconnect.com The sulphonylureas act by triggering insulin release from the pancreatic β
cell. Abstract A specific site on the adenosine triphosphate (ATP)-sensitive
potassium channels is occupied by sulphonylureas leading to closure of the ... Cited by 86 - Related articles - BL Direct - All 7 versions
G Williams - The Lancet, 1994 - Elsevier Meg. Lean, Dietary management of non-insulin dependent diabetes mellitus. In: Jc
Pickup and G. Williams, Editors, Textbook of diabetes, Blackwell Scientific
Publications, Oxford (1991), pp. 453–61. ... HE. Lebovitz, Sulphonylurea ... Cited by 77 - Related articles - BL Direct - All 5 versions
Z Kerenyi, H Samer, R James, Y Yan, M … - Diabetes research and clinical practice, 2004 - Elsevier Aim: To compare the efficacy of combination therapy using rosiglitazone (8 mg
per day) and glibenclamide (7.5 mg per day) with upward titration of
glibenclamide as monotherapy (maximum dose=15 mg per day) in reducing HbA ... Cited by 50 - Related articles - All 8 versions
LS Hermann, B Schersten, A Melander - Diabetic Medicine, 1994 - interscience.wiley.com The short-term (2–12 weeks) antihyperglycaemic efficacy of metformin (M),
glibenclamide (G), and their primary combination (MG) was assessed in a
double-blind study including 165 unselected patients with Type 2 diabetes. ... Cited by 48 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org [PDF] C Abraira, WG Henderson, JA Colwell, FQ … - Diabetes Care, 1998 - Am Diabetes Assoc The feasibility trial for the VA Coopera- tive Study on Glycemic Control and
Complications in Type 2 Diabetes (VA CSDM) evaluated whether near- no rmal gly-
cohemoglobin (HbA1 c) levels could be maintained for a 2-year period with ... Cited by 43 - Related articles - BL Direct - All 7 versions
